Effects of cellular fixatives on human immunodeficiency virus production

J M Cory1, F Rapp, B M Ohlsson-Wilhelm

  • 1Department of Microbiology and Immunology, Pennsylvania State University College of Medicine, Hershey 17033.

Cytometry
|January 1, 1990
PubMed

Insights

Formaldehyde, methanol, and paraformaldehyde fixation effectively inactivate human immunodeficiency virus-1 (HIV-1) in H9 cells, reducing infectivity by over 99.99%. Dimethylsuberimidate fixation was ineffective for HIV-1 inactivation.

Area of Science:

  • Virology
  • Cell Biology
  • Immunology

Background:

  • Flow cytometry is crucial for analyzing cells, including those infected with human immunodeficiency virus-1 (HIV-1).
  • Proper cell fixation is essential for safe handling of infectious samples during flow cytometry.
  • Evaluating fixation effects on HIV-1 infectivity is vital for laboratory safety protocols.

Purpose of the Study:

  • To assess the impact of various cell fixation methods on the infectivity of HIV-1-infected H9 cells.
  • To establish guidelines for selecting appropriate fixation procedures for potentially infectious samples analyzed by flow cytometry.

Main Methods:

  • HIV-1-infected H9 cells were subjected to different fixation treatments (e.g., formaldehyde, methanol, paraformaldehyde, dimethylsuberimidate).
  • Fixed and unfixed infected cells were co-cultured with uninfected H9 cells to assess residual infectivity.
  • Infectivity was measured by detecting cell-associated HIV-1 antigens and reverse transcriptase activity.

Main Results:

  • Thirty-minute fixation with 1.85% formaldehyde, absolute methanol, methanol:acetone (1:1), or 0.5% paraformaldehyde reduced HIV-1 infectivity by over 99.99%.
  • A multi-step fixation procedure using formaldehyde and ethanol also effectively reduced infectivity.
  • Dimethylsuberimidate (3 µg/ml) was ineffective in reducing HIV-1 infectivity.

Conclusions:

  • Standard fixation reagents like formaldehyde and methanol are highly effective in inactivating HIV-1 in H9 cells for flow cytometry.
  • These findings provide critical safety guidelines for laboratories working with HIV-1-infected samples.
  • Dimethylsuberimidate should not be used for inactivating HIV-1 in samples intended for flow cytometry.